BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zubor P, Kubatka P, Kajo K, Dankova Z, Polacek H, Bielik T, Kudela E, Samec M, Liskova A, Vlcakova D, Kulkovska T, Stastny I, Holubekova V, Bujnak J, Laucekova Z, Büsselberg D, Adamek M, Kuhn W, Danko J, Golubnitschaja O. Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management. Int J Mol Sci 2019;20:E2878. [PMID: 31200461 DOI: 10.3390/ijms20122878] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Kudela E, Samec M, Kubatka P, Nachajova M, Laucekova Z, Liskova A, Dokus K, Biringer K, Simova D, Gabonova E, Dankova Z, Biskupska Bodova K, Zubor P, Trog D. Breast Cancer in Young Women: Status Quo and Advanced Disease Management by a Predictive, Preventive, and Personalized Approach. Cancers (Basel) 2019;11:E1791. [PMID: 31739537 DOI: 10.3390/cancers11111791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
2 Nagy B. Cell-Free Nucleic Acids. Int J Mol Sci 2019;20:E5645. [PMID: 31718077 DOI: 10.3390/ijms20225645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Deepak Singh D, Han I, Choi EH, Yadav DK. CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer. Comput Struct Biotechnol J 2021;19:2384-97. [PMID: 34025931 DOI: 10.1016/j.csbj.2021.04.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wang SC, Liao LM, Ansar M, Lin SY, Hsu WW, Su CM, Chung YM, Liu CC, Hung CS, Lin RK. Automatic Detection of the Circulating Cell-Free Methylated DNA Pattern of GCM2, ITPRIPL1 and CCDC181 for Detection of Early Breast Cancer and Surgical Treatment Response. Cancers (Basel) 2021;13:1375. [PMID: 33803633 DOI: 10.3390/cancers13061375] [Reference Citation Analysis]
5 Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol 2020;10:526850. [PMID: 33330019 DOI: 10.3389/fonc.2020.526850] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Moelans CB, Patuleia SIS, van Gils CH, van der Wall E, van Diest PJ. Application of Nipple Aspirate Fluid miRNA Profiles for Early Breast Cancer Detection and Management. Int J Mol Sci 2019;20:E5814. [PMID: 31752362 DOI: 10.3390/ijms20225814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wang F, Xiang Z, Huang T, Zhang M, Zhou WB. ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells. Cancer Manag Res 2020;12:9725-34. [PMID: 33116832 DOI: 10.2147/CMAR.S261828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li J, Guan X, Fan Z, Ching LM, Li Y, Wang X, Cao WM, Liu DX. Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers (Basel) 2020;12:E2767. [PMID: 32992445 DOI: 10.3390/cancers12102767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Sher G, Salman NA, Khan AQ, Prabhu KS, Raza A, Kulinski M, Dermime S, Haris M, Junejo K, Uddin S. Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications. Semin Cancer Biol 2020:S1044-579X(20)30181-4. [PMID: 32858230 DOI: 10.1016/j.semcancer.2020.08.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mahmoud MM, Sanad EF, Elshimy RAA, Hamdy NM. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis. Front Oncol 2021;11:749753. [PMID: 34745973 DOI: 10.3389/fonc.2021.749753] [Reference Citation Analysis]
11 Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A, Marani C, Marshall J, Melino S, Marchetti P, Montanaro M, Natale ME, Novelli F, Palmieri G, Piacentini M, Rendina EA, Roselli M, Sica G, Tesauro M, Rovella V, Tisone G, Shi Y, Wang Y, Melino G. Global mapping of cancers: The Cancer Genome Atlas and beyond. Mol Oncol 2021. [PMID: 34245122 DOI: 10.1002/1878-0261.13056] [Reference Citation Analysis]
12 Adam-Artigues A, Garrido-Cano I, Carbonell-Asins JA, Lameirinhas A, Simón S, Ortega-Morillo B, Martínez MT, Hernando C, Constâncio V, Burgues O, Bermejo B, Henrique R, Lluch A, Jerónimo C, Eroles P, Cejalvo JM. Identification of a Two-MicroRNA Signature in Plasma as a Novel Biomarker for Very Early Diagnosis of Breast Cancer. Cancers (Basel) 2021;13:2848. [PMID: 34200463 DOI: 10.3390/cancers13112848] [Reference Citation Analysis]
13 Valencia-Hernandez I, Peregrina-Barreto H, Reyes-Garcia CA, Lopez-Armas GC. Density map and fuzzy classification for breast density by using BI-RADS. Comput Methods Programs Biomed 2021;200:105825. [PMID: 33190944 DOI: 10.1016/j.cmpb.2020.105825] [Reference Citation Analysis]
14 Patuleia SIS, Moelans CB, Koopman J, van Steenhoven JEC, van Dalen T, van der Pol CC, Jager A, Ausems MGEM, van Diest PJ, van der Wall E, Suijkerbuijk KPM. Patient-centered research: how do women tolerate nipple fluid aspiration as a potential screening tool for breast cancer? BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09795-8] [Reference Citation Analysis]
15 Chyr J, Zhang Z, Chen X, Zhou X. PredTAD: A machine learning framework that models 3D chromatin organization alterations leading to oncogene dysregulation in breast cancer cell lines. Comput Struct Biotechnol J 2021;19:2870-80. [PMID: 34093998 DOI: 10.1016/j.csbj.2021.05.013] [Reference Citation Analysis]
16 Crigna AT, Samec M, Koklesova L, Liskova A, Giordano FA, Kubatka P, Golubnitschaja O. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope? EPMA J 2020;:1-25. [PMID: 33144898 DOI: 10.1007/s13167-020-00226-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
17 Xiang W, Rao H, Zhou L. A meta-analysis of contrast-enhanced spectral mammography versus MRI in the diagnosis of breast cancer. Thorac Cancer 2020;11:1423-32. [PMID: 32233072 DOI: 10.1111/1759-7714.13400] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
18 Ng ET, Ang RZ, Tran BX, Ho CS, Zhang Z, Tan W, Bai Y, Zhang M, Tam WW, Ho RC. Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis. Int J Environ Res Public Health 2019;16:E4970. [PMID: 31817811 DOI: 10.3390/ijerph16244970] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 5.3] [Reference Citation Analysis]
19 Ris F, Hellan M, Douissard J, Nieva JJ, Triponez F, Woo Y, Geller D, Buchs NC, Buehler L, Moenig S, Iselin CE, Karenovics W, Petignat P, Lam GT, Undurraga Malinervo M, Tuttle R, Ouellette J, Bose D, Ismail N, Toso C. Blood-Based Multi-Cancer Detection Using a Novel Variant Calling Assay (DEEPGENTM): Early Clinical Results. Cancers (Basel) 2021;13:4104. [PMID: 34439258 DOI: 10.3390/cancers13164104] [Reference Citation Analysis]
20 Sunday CE, Chowdhury M. Review—Aptamer-Based Electrochemical Sensing Strategies for Breast Cancer. J Electrochem Soc 2021;168:027511. [DOI: 10.1149/1945-7111/abe34d] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Hirschfeld M, Rücker G, Weiß D, Berner K, Ritter A, Jäger M, Erbes T. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection. Mol Diagn Ther 2020;24:215-32. [PMID: 32112368 DOI: 10.1007/s40291-020-00453-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
22 Torres-Urzúa LF, Alva-Sánchez H, Martínez-Dávalos A, García-Pérez FO, Peruyero-Rivas RM, Rodríguez-Villafuerte M. A dedicated phantom design for positron emission mammography performance evaluation. Phys Med Biol 2020;65:245003. [PMID: 32693400 DOI: 10.1088/1361-6560/aba7d1] [Reference Citation Analysis]
23 Haghbin M, Hashemi Tayer A, Kamravan M, Sotoodeh Jahromi A. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer. Asian Pac J Cancer Prev 2021;22:1573-9. [PMID: 34048188 DOI: 10.31557/APJCP.2021.22.5.1573] [Reference Citation Analysis]
24 Aref MH, Aboughaleb IH, Youssef AM, El-Sharkawy YH. Hyperspectral image-based analysis of thermal damage for ex-vivo bovine liver utilizing radiofrequency ablation. Surg Oncol 2021;38:101564. [PMID: 33865183 DOI: 10.1016/j.suronc.2021.101564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Ganguly S, Arora I, Tollefsbol TO. Impact of Stilbenes as Epigenetic Modulators of Breast Cancer Risk and Associated Biomarkers. Int J Mol Sci 2021;22:10033. [PMID: 34576196 DOI: 10.3390/ijms221810033] [Reference Citation Analysis]
26 Patuleia SIS, Suijkerbuijk KPM, van der Wall E, van Diest PJ, Moelans CB. Nipple Aspirate Fluid at a Glance. Cancers (Basel) 2021;14:159. [PMID: 35008326 DOI: 10.3390/cancers14010159] [Reference Citation Analysis]
27 Attari F, Keighobadi F, Abdollahi M, Arefian E, Lotfizadeh R, Sepehri H, Moridi Farimani M. Inhibitory effect of flavonoid xanthomicrol on triple-negative breast tumor via regulation of cancer-associated microRNAs. Phytother Res 2021;35:1967-82. [PMID: 33217075 DOI: 10.1002/ptr.6940] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Holubekova V, Kolkova Z, Grendar M, Brany D, Dvorska D, Stastny I, Jagelkova M, Zelinova K, Samec M, Liskova A, Laucekova Z, Kudela E, Bobrovska M, Kalman M, Zubor P, Dankova Z. Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study. Int J Mol Sci 2020;21:E7288. [PMID: 33023154 DOI: 10.3390/ijms21197288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]